Einstein/Montefiore Department of Medicine

In The Media

U.S. News & World Report interviews Ana Maria Cuervo, M.D., Ph.D., and Nir Barzilai, M.D., about their aging research.  Drs. Cuervo and Barzilai are co-directors of Einstein’s Institute for Aging Research.

(Tuesday, August 09, 2016)

Dr. Cuervo's Profile | Dr. Barzilai's Profile
 
 

Scientific American interviews Ana Maria Cuervo, M.D., Ph.D., about her research connecting defective proteins, neurodegenerative diseases and a cellular cleaning process. 

(Monday, August 01, 2016)

Dr. Cuervo's Profile
 
 

Scientific American interviews Ana Maria Cuervo, M.D., Ph.D., about her research connecting defective proteins, neurodegenerative diseases and a cellular cleaning process. 

(Monday, August 01, 2016)

Dr. Cuervo's Profile
 
 

The Washington Post interviews Snehal Patel, M.D., about his study that found eliminating a blood test could safely increase the number of donor hearts for transplants. Dr. Patel is assistant professor of medicine at Einstein and attending physician at the Montefiore Einstein Center for Heart and Vascular Care.

(Thursday, June 23, 2016)

Dr. Patel's Profile
 
 

Reuters interviews Michal Melamed, M.D., about her research that found many young, obese adults are unaware they are at risk for kidney disease. Dr. Melamed is associate professor of medicine and of epidemiology & population health at Einstein and attending physician, nephrology at Montefiore Health System.

(Friday, June 03, 2016)

Dr. Melamed's Profile
 
 

Los Angeles Times interviews Chinazo Cunningham, M.D., M.S., about buprenorphine, a drug used to treat opioid addiction, for an article on Prince’s death. Dr. Cunningham is associate chief of general internal medicine in the department of medicine at Einstein and Montefiore.

(Tuesday, May 31, 2016)

Dr. Cunningham's Profile
 
 

Nature interviews John Greally, M.B.B.Ch., Ph.D., about his criticism of a recent New Yorker article on epigenetics. Dr. Greally is professor of genetics, of medicine and of pediatrics and the director of the center for epigenomics at Einstein and attending physician at the Children’s Hospital at Montefiore.

(Tuesday, May 10, 2016)

Dr. Greally's Profile
 
 

The New York Times interviews Chinazo Cunningham, M.D., M.S., about the growing acceptance of harm reduction approaches to drug addiction and treatment. Dr. Cunningham notes that these initiatives, which include needle exchanges and safe injection sites, were once rejected but are now being embraced as opioid and heroin addiction has exploded in white, suburban communities. Dr. Cunningham is professor of medicine and of family and social medicine at Einstein and associate chief of the division of general internal medicine at Einstein and Montefiore.

(Wednesday, April 20, 2016)

Dr. Cunningham's Profile
 
 

The Washington Post quotes Marcus Bachhuber, M.D., M.S., and Chinazo Cunningham, M.D., M.S., about their new study with Joanna Starrels, M.D., M.S., on the surge in overdose deaths from benzodiazepines. Dr. Bachhuber notes that this growing public health problem has largely flown under the radar. Dr. Bachhuber is assistant professor of medicine at Einstein and attending physician, Montefiore; Dr. Cunningham is professor of medicine and of family and social medicine at Einstein and associate chief of the division of general internal medicine at Einstein and Montefiore.

(Tuesday, February 23, 2016)

Dr. Bachhuber's Profile | Dr. Cunningham's Profile | Dr. Starrels' Profile
 
 

The New York Times interviews Dr. Nir Barzilai, M.D., about his upcoming clinical trial to determine if an existing FDA-approved drug can extend health span. Dr. Barzilai and his collaborators at the American Federation for Aging Research will investigate if metformin, a cheap and commonly used medication to treat type 2 diabetes, can delay the onset of several age-related diseases. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein.

(Monday, February 01, 2016)

Dr. Barzilai's Profile
 
 

National Geographic highlights the leadership role Nir Barzilai, M.D., is taking in a clinical trial to determine if a common diabetes drug can delay aging. Dr. Barzilai notes that the goal of the Targeting Aging with Metformin (TAME) study is not to find the “fountain of youth,” but to extend the number of healthy, active years humans can enjoy. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein.

(Thursday, December 03, 2015)

Dr. Barzilai's Profile
 
 

The New York Times interviews John Greally, M.B.B.S., Ph.D., about a new study that suggests a father’s experiences may influence the biology of his offspring. Dr. Greally notes the study size was small and therefore not conclusive. However, he suggests that research involving hundreds of subjects may help pin down whether epigenomic factors, namely molecules that turn genes on and off, can be passed down to children. Dr. Greally is professor of genetics, of medicine and of pediatrics and the director of the center for epigenomics at Einstein and attending physician at the Children’s Hospital at Montefiore.

(Thursday, December 03, 2015)

Dr. Greally's Profile
 
 

New York Times interviews Michael Alderman, M.D., about research that found reducing systolic blood pressure below current guidelines can save lives. The study determined that participants whose blood pressure was kept below 120, rather than the current recommended target of 140, had a 25 percent reduction in heart attack, heart failure or stroke, or died from heart disease. This was primarily achieved by providing additional medications. Dr. Alderman urged caution, noting decades-long pill taking by generally healthy people may lead to unintended consequences. Dr. Alderman is distinguished university professor emeritus of epidemiology & population health and of medicine.

(Monday, November 09, 2015)

Dr. Alderman's Profile
 
 

New York Times interviews Kami Kim, M.D., about her research that indicates children with HIV are more likely to develop a severe form of malaria and die. Dr. Kim’s study looked at 3,000 Malawian children who went into comas with cerebral malaria and included autopsies on more than 100 who had died. Dr. Kim is professor of medicine, of microbiology & immunology and of pathology at Einstein and attending physician, infectious disease at Montefiore.

(Tuesday, September 29, 2015)

Dr. Kim's Profile
 
 

The Wall Street Journal reports on a landmark breast cancer study led by Joseph Sparano, M.D. Their research validates a genomic test, which allows many women with early-stage disease to safely skip chemotherapy. Dr. Sparano is vice chairman of medical oncology at Montefiore Einstein Center for Cancer Care, professor of medicine and of obstetrics and gynecology & women's health at Albert Einstein College of Medicine and associate director of clinical research at the NCI-designated Albert Einstein Cancer Center.

(Monday, September 28, 2015)

Dr. Sparano's Profile
 
 
First Page | Previous Page | Page of 14 | Next Page | Last Page
Click here to log in